Artículo

Bibliometric study on the utilization of sorafenib in hepatocellular carcinoma

Resumen

Background: Although the number of studies on sorafenib for hepatocellular carcinoma (HCC) is increasing during the past two decades, no detailed scientometric examination of its knowledge framework has been undertaken. Therefore, we performed a bibliometric analysis on this topic. Methods: VOSviewer and CiteSpace were utilized to analyze the articles regarding sorafenib for HCC from 2005 to 2024, which were retrieved from the Web of Science Core Collection (WoSCC) database. Results: There were 7,667 articles related to sorafenib in HCC were retrieved from the WoSCC database, and they covered 99 countries/regions, 5,640 institutions, and 30,450 authors. The most published literature of countries and institutions were China and Sun Yat-sen University, respectively. Cancers is the journal with the most papers published in this field, and the journal with the most co-citations is N Engl J Med. Among authors, Masatoshi Kudo has published the most research papers, and the most co-citations go to JM Llovet. The keywords “survival”, “apoptosis”, “efficacy”, “transarterial chemoembolization”, “lenvatinib”, etc. represent the current hotspots in this field. Conclusions: We identified current hotspots and trends by bibliometric analysis in sorafenib-HCC field, which might provide valuable guidance for future researches. Further explorations are supposed to conduct the continued study of HCC apoptosis, large-scaled clinical trials with international cooperations, and comprehensive treatments including multiple systemic or locoregional approaches in patients with HCC.
Meng, Wenjun (57813873100); Luo, Yihang (59502266600); Zhao, Lu (59502067700); Zhang, Yaoyu (57909388300); Liu, Jiyan (55667283400); Li, Shadan (27168422900); Du, Yang (55549120800); Li, Hongshuai (57220870054)
Bibliometric study on the utilization of sorafenib in hepatocellular carcinoma
2024
10.3389/fonc.2024.1507608
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85214216602&doi=10.3389%2ffonc.2024.1507608&partnerID=40&md5=591efde2b953fbad4aa00b22b7ea8913
Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China; Department of Urology, The General Hospital of Western Theater Command, Chengdu, China
All Open Access; Gold Open Access
Scopus
Artículo obtenido de:
Scopus
Fuente
0 0 votos
Califica el artículo
Subscribirse
Notificación de
Campus Samborondón
Vía Samborondón Km. 13.5
Call Center: 5150400
metricas@ecotec.edu.ec
Facebook Instagram Youtube

Mapa del sitio